newsfilter
← Latest News
GlobeNewswire·

Sema4 and BioSymetrics Partner on Data-Driven Drug Discovery to Advance Precision Medicine

STAMFORD, Conn. and BOSTON and TORONTO, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Sema4 (NASDAQ:SMFR), an AI-driven genomic and clinical data intelligence platform company, and BioSymetrics, a phenomics-driven drug discovery company, today announced a strategi